Scientific Review Committee

Each of our Research Scholars Programs is overseen by a scientific review committee composed of distinguished experts in their respective fields who are independent from Gilead to ensure equal, objective evaluation of all applicants and their applications. This enables us to maintain the program’s overall integrity and competitive standards, and to ensure awards support the next generation of breakthrough scientific discovery.

Chair

Evandro de Azambuja, MD, PhD

Head of Medical Support Team - ATPT
Institut Jules Bordet

Review Committee

Lucia Del Mastro, MD

Director of Medical Oncology Unit
IRCCS Ospedale Policlinico San Martino

Professor of Oncology
University of Genova

Sheeba Irshad, MD, PhD

Professor, Cancer Immunology
King's College London

Concultant Medical Oncologist
Guy's & St. Thomas NHS Tryst, London

Nadia Harbeck, MD, PhD

Director, Breast Cancer
Professor, Chair for Conservative Oncology

University of Munich (LMU)

Domenica Lorusso, MD, PhD

Professor
Humanitas University

Head of Gynecologic Oncology Unit
Humanitas San Pio X Hospital

Christophe Borg, MD, PhD

Professor of Medical Oncology
University Hospital of Besançon

Professor
University of Franche Comté and INSERM

Enriqueta Felip, MD, PhD

Professor of Medicine
Section in Chief, Medical Oncology Department Head, Thoracic Oncology Unit

Vall D'Hebron University Hospital

Jarushka Naidoo, MBBCH, MHS

Professor of Medical Oncology
RCSI University of Health Sciences

Consultant Medical Oncologist
Beaumont Hospital

Review the scoring criteria considered for applications

Application Deadline

11:59 PM CET

13 Mar 2026

Grant Amount

3 Awards

$180,000